Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,165.08
(
0.80%
)
US TECH 100
26,538.40
(
1.85%
)
Dow Jones
49,247.66
(
-0.13%
)
Brent Oil
100.66
(
0.00%
)
Bitcoin
77,500.34
(
0.04%
)
News Focus
News Focus
Post# of 405181
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

hockeypond

Send PM Follow Ignore
Followers 46
Posts 4290
Boards Moderated 0
Alias Born 08/21/2003

hockeypond

Re: crashco post# 345040

Tuesday, 02/09/2021 3:09:08 PM

Tuesday, February 09, 2021 3:09:08 PM

Post# of 405181
It seemed that the article suggested to "combine" Remdesivir with Brilacidin. The comment below supports this:

A desirable outcome for any potential COVID-19 therapeutic will be its ability to synergize with existing COVID-19 treatments, particularly if the mechanisms of action of the synergistic treatments can impact more than one step of the viral lifecycle.

Seems a little "political" to me....just curious wouldn't Gilead Sciences want to partner with IPIX because of this?
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote